v3.26.3
Note 5 - Stock Incentive Plan 1 (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 05, 2024
Mar. 31, 2022
Apr. 30, 2020
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2026
Apr. 27, 2026
Oct. 31, 2017
Apr. 30, 2016
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) [1]           156,812      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)         0        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value         $ 22,600 $ 22,600      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Outstanding, Aggregate Intrinsic Value         $ 6,500 $ 6,500      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)         $ 43,940,000 $ 43,940,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Exercise Price (in dollars per share)         28,550,000 28,550,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)         $ 68,220,000 $ 68,220,000      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount         $ 23,600 $ 23,600      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)           3 years 3 months 18 days      
Share-Based Payment Arrangement, Expense, Tax Benefit           $ 0      
Vesting Monthly Over One Year [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)           2,000      
Vesting Quarterly Over Half One Year [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)           1,284      
Vesting 6/48ths on Six-months and 1/48th After [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)           153,528      
Restricted Stock Units (RSUs) [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) [2]           0      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)   1,020,000 620,000         320,000 140,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)   400,000 300,000            
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)           10 years      
Monopar Therapeutics Inc. 2016 Amended Stock Incentive Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) 1,420,000                
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares) 400,000     400,000          
Monopar Therapeutics Inc. 2016 Amended Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)           156,812      
Monopar Therapeutics Inc. 2016 Amended Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Minimum [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)         $ 53.29 $ 53.29      
Monopar Therapeutics Inc. 2016 Amended Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Maximum [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)         $ 119.21 $ 119.21      
Monopar Therapeutics Inc. 2026 Stock Incentive Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)             600,000    
[1] 156,812 options vest as follows: options to purchase 2,000 shares of the Company’s common stock vest monthly over one year; options to purchase 1,284 shares of the Company's common stock vest 50% on September 30, 2026, and 50% on December 31, 2026; options to purchase 153,528 shares of the Company’s common stock vest 6/48ths on the six-month anniversary of the vesting commencement date and 1/48th per month thereafter.
[2] There were no restricted stock units granted during the three and nine months ended September 30, 2026.